Insights

Portfolio Manager, James Rodda explains why Alphabet Inc. is a great example of pragmatic value. 
Antipodes Portfolio Manager Vihari Ross takes the audience on a journey through the airline industry, focusing on Airbus (EPA:AIR), at the 2024 Sohn Hearts & Minds Conference.
In this interview series with Livewire Markets, emerging markets portfolio manager, John Stavliotis, discusses why investors should consider allocating to emerging market equities, and shares insights into Antipodes’ approach to investing in the asset class. 
Antipodes’ Jacob Mitchell and Magellan’s Arvid Streimann where discuss five businesses who have controversial leaders, and whether they believe the resulting stocks are a ‘buy’ ‘hold’ or ‘sell’.
Gordon Ip (Portfolio Manager, Antipodes Asia Income Fund) joins Jonathan Wu (Investment Director – Asia) providing an overview of the Antipodes Asia Income Fund.
Global equities have fallen 16% this year (to June 30) as Central Banks set their sights firmly on reducing inflation, despite growing concerns around economic activity.
Tech stocks have borne the brunt of the recent sell off in equity markets and with the Nasdaq firmly in bear market territory, it is unprofitable tech stocks that have been hit the hardest – down almost 60% this year.
Antipodes has owned Meta (previously Facebook) since the end of 2018 and despite the recent volatility in which many sold out of the company, it remains one of our top 20 holdings. 
Alison Savas discusses the key issues impacting markets in Q1 2022 along with how Antipodes has been positioning its portfolios.
A major demographic shift is underway – and it’s creating one of the most significant long-term opportunities.
Antipodes Founder and Portfolio Manager James Rodda recently provided a webinar introduction to the Antipodes Global SMID Active ETF (ASX:MIDS).
In this Livewire Markets interview, James Rodda discusses the Antipodes Global SMIDS strategy and why now could be a good time look at allocating to global small and mid caps.
In this Livewire Markets interview, James Rodda shares how he is uncovering value and managing risk in global small and mid-cap equities as markets shift and new themes emerge.
Portfolio Manager, Vihari Ross and Investment Director, Alison Savas provide a market and portfolio positioning update for Q3 2025. 
The investment case for Brazil’s Nubank.
With a 20% discount to the S&P 500 and faster growth than peers, Alphabet represents a classic mispriced opportunity for pragmatic investors seeking growth at a relative discount.
Watch a feature interview with Antipodes CIO Jacob Mitchell on Livewire Markets.
A replay of Jacob Mitchell’s presentation at the 2025 Pinnacle Investment Summit, held in July 2025. 
Antipodes portfolio manager, Nick Cameron, outlines the investment case for US medical device company, Globus Medical.

Now available on the ASX: the Antipodes Global SMID Active ETF (ASX:MIDS)

X